Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
- PMID: 24209497
- PMCID: PMC3827997
- DOI: 10.1186/1476-511X-12-171
Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies
Abstract
Along with rising numbers of patients with metabolic syndrome, the prevalence of nonalcoholic fatty liver disease (NAFLD) has increased in proportion with the obesity epidemic. While there are no established treatments for NAFLD, current research is targeting new molecular mechanisms that underlie NAFLD and associated metabolic disorders. This review discusses some of these emerging molecular mechanisms and their therapeutic implications for the treatment of NAFLD. The basic research that has identified potential molecular targets for pharmacotherapy will be outlined.
Similar articles
-
Nuclear receptors and nonalcoholic fatty liver disease.Biochim Biophys Acta. 2016 Sep;1859(9):1083-1099. doi: 10.1016/j.bbagrm.2016.03.002. Epub 2016 Mar 4. Biochim Biophys Acta. 2016. PMID: 26962021 Free PMC article. Review.
-
PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.Toxicol Appl Pharmacol. 2014 Apr 1;276(1):73-81. doi: 10.1016/j.taap.2014.02.001. Epub 2014 Feb 15. Toxicol Appl Pharmacol. 2014. PMID: 24534255
-
Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.Gastroenterology. 2008 Feb;134(2):556-67. doi: 10.1053/j.gastro.2007.11.037. Epub 2007 Nov 28. Gastroenterology. 2008. PMID: 18242221
-
Current pharmacological treatment of nonalcoholic fatty liver.Curr Med Chem. 2006;13(24):2889-900. doi: 10.2174/092986706778521878. Curr Med Chem. 2006. PMID: 17073635 Review.
-
The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Mol Aspects Med. 2017 Aug;56:34-44. doi: 10.1016/j.mam.2017.04.004. Epub 2017 May 5. Mol Aspects Med. 2017. PMID: 28442273 Free PMC article. Review.
Cited by
-
The HIV matrix protein p17 induces hepatic lipid accumulation via modulation of nuclear receptor transcriptoma.Sci Rep. 2015 Oct 15;5:15403. doi: 10.1038/srep15403. Sci Rep. 2015. PMID: 26469385 Free PMC article.
-
The Potential of Lamiaceae Herbs for Mitigation of Overweight, Obesity, and Fatty Liver: Studies and Perspectives.Molecules. 2022 Aug 8;27(15):5043. doi: 10.3390/molecules27155043. Molecules. 2022. PMID: 35956991 Free PMC article. Review.
-
Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver.Redox Biol. 2018 Apr;14:295-304. doi: 10.1016/j.redox.2017.09.018. Epub 2017 Sep 27. Redox Biol. 2018. PMID: 28987868 Free PMC article.
-
Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver.Sci Rep. 2019 Jul 22;9(1):10596. doi: 10.1038/s41598-019-46664-0. Sci Rep. 2019. PMID: 31332246 Free PMC article.
-
FoxO1 is a critical regulator of hepatocyte lipid deposition in chronic stress mice.PeerJ. 2019 Sep 27;7:e7668. doi: 10.7717/peerj.7668. eCollection 2019. PeerJ. 2019. PMID: 31579588 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous